Credit Suisse Ag Sight Sciences, Inc. Transaction History

Credit Suisse Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.88 - $8.8 $1,339 - $4,092	-465 Reduced 1.52%	30,217 $101,000
Q2 2023 Aug 11, 2023	BUY	$7.46 - $10.67 $51,653 - $73,879	6,924 Added 29.14%	30,682 $254,000
Q1 2023 May 10, 2023	BUY	$8.44 - $13.35 $200,509 - $317,155	23,757 Added 2375700.0%	23,758 $207,000
Q4 2022 Feb 13, 2023	SELL	$5.58 - $13.94 $669 - $1,672	-120 Reduced 99.17%	1 $0
Q3 2022 Nov 10, 2022	BUY	$6.1 - $11.41 $597 - $1,118	98 Added 426.09%	121 $1,000
Q2 2022 Aug 12, 2022	BUY	$6.61 - $11.99 $152 - $275	23 New	23 $0

21.3M

30.7K

18.6K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $290M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.